End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
- EUR | -.--% | -.--% | -.--% |
2017 | Neuron BioLabs, S.L. cancelled the acquisition of diagnostics operations, R&D services and patents of Alzheimer's disease from Neuron Bio, SA. | CI |
2017 | Neol Biosolutions Seeks Investors | CI |
1st Jan change | Capi. | |
---|---|---|
-.--% | 5.19M | |
+7.53% | 111B | |
+11.40% | 106B | |
-12.49% | 22.24B | |
+0.44% | 21.25B | |
-4.18% | 18.97B | |
-37.85% | 18.52B | |
-8.52% | 16.81B | |
+37.95% | 12.54B | |
-24.27% | 8.09B |
- Stock Market
- Equities
- NEU Stock
- News Neuron Bio, S.A.
- Neuron Bio, SA Auditor Raises 'Going Concern' Doubt